Quartz Partners’s AbbVie ABBV Stock Holding History

Quartz Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.04M	Hold	8,106	–	–	0.67%	42
2026 Q1	$1.76M	Sell	8,106 -216	-3%	-$47.9K	0.68%	43
2025 Q4	$1.9M	Sell	8,322 -550	-6%	-$125K	0.71%	39
2025 Q3	$2.05M	Buy	8,872 +809	+10%	+$165K	0.74%	35
2025 Q2	$1.5M	Buy	8,063 +172	+2%	+$32K	0.68%	42
2025 Q1	$1.65M	Sell	7,891 -825	-9%	-$160K	1%	31
2024 Q4	$1.55M	Buy	8,716 +272	+3%	+$50K	0.94%	27
2024 Q3	$1.67M	Buy	+8,444	New	+$1.58M	1.04%	26

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Quartz Partners's ABBV Position: Q2 2026 in Review

Quartz Partners held its AbbVie (ABBV) position steady in Q2 2026 at 8,106 shares worth $2.04M. The position accounts for 0.67% of the portfolio, ranked #42.

Quartz Partners first reported a position in ABBV in Q3 2024 and has held it in 8 quarters since. The position peaked at $2.05M in Q3 2025. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Quartz Partners held 8,106 shares of AbbVie worth $2.04M as of Q2 2026.
Quartz Partners left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.67% of Quartz Partners's portfolio in Q2 2026, its #42 holding.
Quartz Partners first reported a position in AbbVie in Q3 2024 and has held it in 8 quarters since.
Quartz Partners's AbbVie position peaked at $2.05M in Q3 2025.
4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Quartz Partners's 13F filing for Q2 2026, filed 10 Aug 2026.